Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

PYK2 expression and phosphorylation increases in pressure overload-induced left ventricular hypertrophy

PYK2 expression and phosphorylation increases in pressure overload-induced left ventricular... Abstract Proline-rich tyrosine kinase 2 (PYK2) is a member of the focal adhesion kinase (FAK) family of nonreceptor protein tyrosine kinases. PYK2 has been implicated in linking G protein-coupled receptors to activation of mitogen-activated protein kinase cascades and cellular growth in a variety of cell types. To determine whether PYK2 expression and phosphorylation is altered in left ventricular (LV) myocardium undergoing LV hypertrophy (LVH) and heart failure in vivo, suprarenal abdominal aortic coarctation was performed in 160-g male Sprague-Dawley rats. Immunohistochemistry and Western blotting were performed on LV tissue 1, 8, and 24 wk after aortic banding. Aortic banding produced sustained hypertension and gradually developing LVH. PYK2 levels were increased 1.8 ± 0.2-, 2.7 ± 0.6-, and 2.0 ± 0.2-fold in 1-, 8-, and 24-wk banded animals compared with their respective sham-operated controls. The increase in PYK2 expression was paralleled by an increase in PYK2 phosphorylation, both of which preceded the development of LVH. Immunohistochemistry revealed that enhanced PYK2 expression occurred predominantly in the cardiomyocyte population. Furthermore, there was a high degree of correlation ( R = 0.75; P < 0.001) between the level of PYK2 and the degree of LVH in 24-wk sham and banded animals. In contrast, FAK levels and FAK phosphorylation were not increased before the development of LVH. However, there was a high degree of correlation (R = 0.68; P < 0.001) between the level of FAK and the degree of LVH in 24-wk sham and banded rats. There was also a significant increase in the ratio of phosphospecific anti-FAK to FAK at this time point. These data are consistent with a role for PYK2 in the induction of pressure overload-induced cardiomyocyte hypertrophy, and suggest that PYK2 and FAK have distinctly different roles in LVH progression. signal transduction cytoskeleton heart failure focal adhesion kinase Footnotes This study was supported in part by National Heart, Lung, and Blood Institute Grants HL-34328 and HL-63711 and Service Awards F32 HL-10313 (to A. L. Bayer) and F32 HL-68476 (to M. C. Heidkamp). This study was also supported by a gift from the Dr. Ralph and Marian Falk Trust for Medical Research. Address for reprint requests and other correspondence: A. M. Samarel, The Cardiovascular Institute, Bldg. 110, Rm. 5222, Loyola University Medical Center, 2160 S. First Ave., Maywood, IL 60153 (E-mail: [email protected] ). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “ advertisement ” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. April 25, 2002;10.1152/ajpheart.00021.2002 Copyright © 2002 the American Physiological Society http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png AJP - Heart and Circulatory Physiology The American Physiological Society

PYK2 expression and phosphorylation increases in pressure overload-induced left ventricular hypertrophy

Download PDF
13 pages

Loading next page...
 
/lp/the-american-physiological-society/pyk2-expression-and-phosphorylation-increases-in-pressure-overload-490bKgsutQ

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
The American Physiological Society
Copyright
Copyright © 2011 the American Physiological Society
ISSN
0363-6135
eISSN
1522-1539
DOI
10.1152/ajpheart.00021.2002
pmid
12124218
Publisher site
See Article on Publisher Site

Abstract

Abstract Proline-rich tyrosine kinase 2 (PYK2) is a member of the focal adhesion kinase (FAK) family of nonreceptor protein tyrosine kinases. PYK2 has been implicated in linking G protein-coupled receptors to activation of mitogen-activated protein kinase cascades and cellular growth in a variety of cell types. To determine whether PYK2 expression and phosphorylation is altered in left ventricular (LV) myocardium undergoing LV hypertrophy (LVH) and heart failure in vivo, suprarenal abdominal aortic coarctation was performed in 160-g male Sprague-Dawley rats. Immunohistochemistry and Western blotting were performed on LV tissue 1, 8, and 24 wk after aortic banding. Aortic banding produced sustained hypertension and gradually developing LVH. PYK2 levels were increased 1.8 ± 0.2-, 2.7 ± 0.6-, and 2.0 ± 0.2-fold in 1-, 8-, and 24-wk banded animals compared with their respective sham-operated controls. The increase in PYK2 expression was paralleled by an increase in PYK2 phosphorylation, both of which preceded the development of LVH. Immunohistochemistry revealed that enhanced PYK2 expression occurred predominantly in the cardiomyocyte population. Furthermore, there was a high degree of correlation ( R = 0.75; P < 0.001) between the level of PYK2 and the degree of LVH in 24-wk sham and banded animals. In contrast, FAK levels and FAK phosphorylation were not increased before the development of LVH. However, there was a high degree of correlation (R = 0.68; P < 0.001) between the level of FAK and the degree of LVH in 24-wk sham and banded rats. There was also a significant increase in the ratio of phosphospecific anti-FAK to FAK at this time point. These data are consistent with a role for PYK2 in the induction of pressure overload-induced cardiomyocyte hypertrophy, and suggest that PYK2 and FAK have distinctly different roles in LVH progression. signal transduction cytoskeleton heart failure focal adhesion kinase Footnotes This study was supported in part by National Heart, Lung, and Blood Institute Grants HL-34328 and HL-63711 and Service Awards F32 HL-10313 (to A. L. Bayer) and F32 HL-68476 (to M. C. Heidkamp). This study was also supported by a gift from the Dr. Ralph and Marian Falk Trust for Medical Research. Address for reprint requests and other correspondence: A. M. Samarel, The Cardiovascular Institute, Bldg. 110, Rm. 5222, Loyola University Medical Center, 2160 S. First Ave., Maywood, IL 60153 (E-mail: [email protected] ). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “ advertisement ” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. April 25, 2002;10.1152/ajpheart.00021.2002 Copyright © 2002 the American Physiological Society

Journal

AJP - Heart and Circulatory Physiology – The American Physiological Society

Published: Aug 1, 2002

There are no references for this article.